• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 50 pages
Exam (elaborations)

NR341 PHARM TEST questions and answers with solutions 2025

Document preview thumbnail
Preview 4 out of 50 pages

NR341 PHARM TEST questions and answers with solutions 2025

Content preview

NR341 PHARM TEST questions and answers
with solutions 2025

Albuterol Contraindications/Precautions - ANSWER cardiac disease, HPT, hyperthyroidism,
diabetes, glaucoma, seizure disorders



Albuterol Indiciations - ANSWER adrenergic used as a bronchodilator to control & prevent
reversible airway obstruction caused by asthma or COPD



Albuterol Side Effects - ANSWER nervousness, restlessness, tremor, HA, insomnia (occurs more
in children), hyperactivity in children, paradoxical bronchospasm (due to excessive use of
inhales), chest pain, palpitations, angina, arrhythmias, HPT, N/V, hyperglycemia, hypokalemia,
tremor



Albuterol Interactions - ANSWER MAOI's lead to hypertensive crisis; beta blockers negate
therapeutic effect; decrease digoxin levels; risk of hypokalemia increases w/use of K+ losing
diuretics (hypokalemia increases the risk of digoxin toxicity); use w/caffeine-containing herbs
(cola nut, guarana, tea, coffee) increases stimulant effect



Albuterol Nursing Implications - ANSWER monitor/report tachycardia, heart palpitations, &
chest pain; monitor/report tremors



Albuterol Patient Teaching - ANSWER report chest pain & heart palpitations; report increase in
pulse rate; avoid caffeine; notify PCP if tremors interfere with ADLs



T-PA Indications - ANSWER tissue plasminogen activator & recombinant approved by the U.S
FDA for IV thrombolysis in acute ischemic stroke w/in 3 hours of onset of stroke symptoms; only
approved for PT's 18yo & older

,t-PA - ANSWER Alteplase



Albuterol - ANSWER Ventolin



T-PA Precautions/Contraindications - ANSWER unclear time/unwitnessed symptom onset/last
known baseline state greater than 3-4.5 hrs; current or HX of IC hemorrhage; CT showing
hypoattenuation or hypoperfusion representing irreversible injury; recent (w/in 3 months)
ischemic stroke, severe head trauma, or intracranial/intraspinal surgery; Subarachnoid
hemorrhage; GI malignancy or GI bleed within 21 days of stroke event; IC conditions that may
increase risk of bleeding (such as intracranial neoplasm, arteriovenous malformation, or
aneurysm); Coagulopathy; Low molecular weight heparin (LMWH) treatment doses within the
previous 24 hrs; Current use of anticoagulant with INR > 1.7 or PT > 15 seconds; Current use of
direct thrombin inhibitors or direct factor Xa inhibitors w/elevated laboratory tests; Concurrent
use of glycoprotein IIb/IIIa receptor inhibitors; Infective endocarditis; Aortic arch dissection;
Intra-axial intracranial neoplasm - lesions located within the brain tissue



T-PA Adverse Effects - ANSWER Bleeding (most common); Orolingual angioedema; Arrhythmias;
Hypotension; Edema; Cholesterol embolization; Venous thrombosis; Re-embolization of deep
venous thrombi (DVT) in patients with pulmonary embolims; Nausea; Vomiting; Hypersensitivity
reactions



T-PA Interactions - ANSWER Warfarin; aspirin (ASA); NSAID's (Ibuprofen, Naproxen,
Nabumetone, and platelet inhibitors such as-Plavix, Effeint, Kengreal, and Brilinta); BC Alteplase
breaks down clots & interferes w/the body's ability to stop bleeding, any drugs that also
interfere w/the body's ability to form blood clots can increase the risk of bleeding in patients



T-PA Patient Teaching - ANSWER must be used w/in 8 hrs of being opened; can alter the test
results of coagulation & fibrinolytic activity tests; have patient immediately report to the PCP
any signs of bleeding (vomiting blood or vomit that looks like coffee grounds; coughing up
blood; hematuria; black, red, or tarry stools; bleeding from the gums; abnormal vaginal
bleedings; bruises without a reason or that get better); immediately report to the PCP any signs
of DVT (edema, warmth, numbness, change in color, or pain in the extremities); report to PCP

,any severe cerebrovascular disease (change in strength on 1 side is greater than the other,
difficulty speaking or thinking, change in balance, or visual changes)



Amiodarone - ANSWER Cordarone



Amiodarone Indications - ANSWER class III potassium channel blocker that manages life-
threatening ventricular-tachycardia or fibrillation that's resistant to other drugs; may treat some
atrial dysrhythmias, such as atrial fibrillation



Amiodarone Contraindications/Precautions - ANSWER cardiogenic shock; sick sinus syndrome,
2nd- or 3rd-degree AV block, bradycardia leading to syncope without a functioning pacemaker;
any known hypersensitivity to the drug or to any of its components, including iodine; pulmonary
toxicity; hepatic injury; worsened arrhythmia; visual impairment or loss of vision; thyroid
abnormalities; bradycardia; implantable cardiac devices; fetal toxicity; peripheral neuropathy;
photosensitivity & skin discoloration; surgery



Amiodarone Adverse Effects - ANSWER N/V; constipation; pulmonary toxicity w/ pneumonitis
(causing fever, cough, SOB), occurs most frequently w/ long-term and/or high-dose use and may
lead to pulmonary fibrosis); visual effects-optic neuropathy w/possible blindness & corneal
microdeposits, which may cause severe sensitivity to light, blurred vision; cardia effects-
bradycardia & hypotension (common w/ IV dose); heart failure may be worsened by
amiodarone therapy; blue-grey discoloration of the skin; CNS effects-dizziness, tremor,
hallucinations



Amiodarone Interactions - ANSWER QT prolonging drugs (class I and III antiarrhythmics, lithium,
tricyclic antidepressants, azole antifungals, etc.)- increase risk of Torsade de Pointes; Neg.
chronotropes (digoxin, beta blockers, verapamil, diltiazem, clonidine, ivabradine)- can result in
bradycardia, sinus arrest, and AV block; St. John's Wort & Cholestyramine can reduce the levels
of amiodarone; warfarin can result in serious or fatal bleeding; fentanyl can cause hypotension,
bradycardia, & decreased cardiac output

, Amiodarone Nursing Implications - ANSWER reduce dose for severe GI symptoms; test baseline
chest x-ray & pulmonary function before starting therapy BC the drug can cause pulmonary
toxicity w/ pneumonitis (causing fever, cough, SOB); monitor pulmonary function testing results
periodically; auscultate breath sounds & report changes or adventitious sounds; monitor for
changes in vision, light sensitivity; monitor pulse & BP, & report VS below the prescribed
parameters; monitor cardiac rhythm constantly during infusion; monitor for weight changes &
edema for both IV & oral therapy; monitor for blue-grey discoloration of skin; report CNS effects



Amiodarone Patient Teaching - ANSWER take w/food or milk if N/V or constipation occur (but be
sure to take at consistent times during the day); comply w/chest x-ray & pulm function testing;
report fever, dry cough, SOB, or other resp symptoms; report sensitivity to light & changes in
vision; obtain regular ophthalmic checkups; wear sunglasses; report dizziness, syncope; for oral
therapy, monitor pulse rate & report rates slower than 60BPM; report weight gain & edema; be
aware that skin discoloration may occur; report tremor, dizziness, hallucinations; avoid
hazardous activity such as driving if dizziness occurs; due to long half-life of this drug, avoid
pregnancy & breastfeeding during therapy & for several months after therapy is discontinued



Amlodipine - ANSWER Norvasc



Amlodipine Indications - ANSWER calcium channel blocker used to treat hypertension and
angina



Amlodipine Adverse Effects - ANSWER dry mouth; facial flushing; nausea, vomiting; stomach
gas, pain; tired, weak; trouble sleeping; fluid retention in the legs, arms, or hands; visible water
retention; dizzy, drowsiness



Amlodipine Interactions - ANSWER any products that have ingredients that can raise your BP,
such as cough-and-cold products, diet aids, or NSAIDs like Motrin or naproxen



Amlodipine Nursing Implications - ANSWER monitor BP for therapeutic effectiveness; monitor
S/S of dose-related peripheral or facial edema that may be accompanied by weight gain;

Document information

Uploaded on
April 8, 2025
Number of pages
50
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
$13.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Performance
4.3
(245)
Sold
594
Followers
45
Items
20030
Last sold
1 day ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions